NCT04358406 2023-11-28Rhu-pGSN for Severe Covid-19 PneumoniaBioAegis Therapeutics Inc.Phase 2 Completed64 enrolled 17 charts
NCT02000817 2019-06-24Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus PatientsGlaxoSmithKlinePhase 1/2 Completed30 enrolled 21 charts